Glenmark Pharma gets DCGI nod for clinical trials of Favipiravir tablets on COVID-19 patients
By Economic Times – Glenmark Pharma gets DCGI nod for clinical trials of Favipiravir tablets on COVID-19 patients The drug sold under brand name Avigan by Fujifilm Toyama Chemical has demonstrated activity against influenza viruses and has been approved in Japan for the treatment of novel influenza virus infections.Last Updated: Apr 30, 2020, 12.29 PM ISTAFPGlenmark Pharmaceuticals on Thursday said that it has received the Indian drug controller’s approval to conduct clinical trial on Favipiravir , the anntiviral drug that is being used in the treatment of Covid-19 in few countries. The drug sold under brand name Avigan by Fujifilm Toyama Chemical has demonstrated activity against influenza viruses and has been approved in Japan for the treatment of novel influenza virus infections. Fujifilm too has started phase 3 trial on this drug and also increased its production. Glenmark’s announcement comes at a time when another Indian company, Strides Pharma said that it has already started